Common Contracts
5 similar Executive Employment Agreement contracts by Axonics Modulation Technologies, Inc., Axonics, Inc.
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 1st, 2023 • Axonics, Inc. • Surgical & medical instruments & apparatus • California
This Amended and Restated Executive Employment Agreement (this “Agreement”) is dated as of June 5, 2019 by and between Axonics Modulation Technologies, Inc., a Delaware corporation (the “Company”), and Alfred Ford Jr. (“Executive”).
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 1st, 2023 • Axonics, Inc. • Surgical & medical instruments & apparatus • California
This Amended and Restated Executive Employment Agreement (this “Agreement”) is dated as of June 6, 2019 by and between Axonics Modulation Technologies, Inc., a Delaware corporation (the “Company”), and John Woock, Ph.D. (“Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 5th, 2019 • Axonics Modulation Technologies, Inc. • Surgical & medical instruments & apparatus • California
This Executive Employment Agreement (this “Agreement”) is dated as of June 5th, 2019 by and between Axonics Modulation Technologies, Inc., a Delaware corporation (the “Company”), and Raymond W. Cohen (“Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 5th, 2019 • Axonics Modulation Technologies, Inc. • Surgical & medical instruments & apparatus • California
This Executive Employment Agreement (this “Agreement”) is dated as of June 5, 2019 by and between Axonics Modulation Technologies, Inc., a Delaware corporation (the “Company”), and Rinda Sama (“Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 5th, 2019 • Axonics Modulation Technologies, Inc. • Surgical & medical instruments & apparatus • California
This Executive Employment Agreement (this “Agreement”) is dated as of June 5, 2019 by and between Axonics Modulation Technologies, Inc., a Delaware corporation (the “Company”), and Dan L. Dearen (“Executive”).
